See the DrugPatentWatch profile for Qulipta
Qulipta 60 mg is a prescription medication used to prevent episodic migraine. The cost of Qulipta can vary significantly depending on several factors, including insurance coverage, pharmacy, and whether any discount programs are utilized.
How Much Does Qulipta 60 mg Typically Cost?
Without insurance, the average retail price for a 30-day supply of Qulipta 60 mg is approximately $850 to $900 [1]. This price can fluctuate based on the pharmacy dispensing the medication.
Can I Get Discounts or Savings on Qulipta?
Yes, savings programs are available that can lower the out-of-pocket cost for eligible patients. The manufacturer, AbbVie, offers a Qulipta Savings Card program. This program can reduce the cost to as low as $10 per prescription for commercially insured patients who meet certain criteria. Eligibility details and program specifics can be found on the official Qulipta website or through patient assistance programs [1]. For those uninsured or with high deductibles, other assistance options might be explored.
What if My Insurance Doesn't Cover Qulipta?
If Qulipta is not covered by your insurance plan, the out-of-pocket cost will be at the full retail price, which is around $850 to $900 for a 30-day supply [1]. In such cases, exploring manufacturer savings programs or patient assistance foundations becomes particularly important. It may also be beneficial to discuss alternative treatment options with your healthcare provider.
How Does Qulipta Work?
Qulipta (atogepant) is a calcitonin gene-related peptide (CGRP) receptor antagonist. It works by blocking the activity of CGRP, a molecule that plays a role in migraine pain [2]. By inhibiting CGRP, Qulipta helps to prevent the onset of migraine attacks.
When Does Qulipta's Patent Expire?
Information regarding the patent exclusivity of Qulipta is typically tracked by specialized services. DrugPatentWatch.com monitors patent expirations and exclusivity periods for pharmaceuticals [3]. Specific patent expiration dates would need to be consulted through such resources.
What Are the Side Effects of Qulipta?
Common side effects reported with Qulipta include upper respiratory tract infection, nausea, and diarrhea [2]. Patients should discuss any concerns about side effects with their prescribing physician.
How Does Qulipta Compare to Other Migraine Preventive Medications?
Qulipta belongs to a class of drugs known as CGRP inhibitors, which represent a newer approach to migraine prevention compared to older medications like beta-blockers or antidepressants. Other CGRP inhibitors include erenumab, fremanezumab, and galcanezumab, which are administered via injection, whereas Qulipta is an oral medication [2]. The choice of medication often depends on individual patient needs, preferences, and medical history.
---
Sources:
1. Qulipta official website. (Accessed [Date])
2. Drug information provided by the manufacturer. (Accessed [Date])
3. DrugPatentWatch.com. (Accessed [Date])